We identified decreased gene and protein expression levels of MGL in esophageal epithelial cells of patients with active EoE, which led to increased levels of the endocannabinoid 2-AG that has the potential to recruit and activate human or mouse eosinophils via its action on CB2. The gene discussed is MGLL; the disease is eosinophilic esophagitis.